Sangamo Therapeutics, Inc. (SGMO)

Overall, these indicators collectively ... for SGMOQ. Sangamo Therapeutics disclosed 62 risk factors in its most recent earnings report. Sangamo Therapeutics reported the most risks in the "Tech & Innovation" category. Finance & Corporate - Financial and accounting risks. Risks related to the execut…

Get real-time Sangamo Therapeutics Inc (SGMO) stock price, news, financials, community insights, and trading ideas. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.

To see the full list of analyst ... the SGMO Stock Forecast page. ... According to Spark, TipRanks’ AI Analyst, SGMO is a Neutral. The score is held down primarily by weak financial performance (declining revenue, large losses, heavy cash burn, and negative equity implying high financing/dilution ri…

A selloff in Samsung Electronics Co. shares Tuesday, despite stronger-than-expected preliminary earnings, underscored the tendency of the stock’s investors to cash out as the market often prices in its milestones ahead of time.

Sangamo Therapeutics Inc (NASDAQ:SGMO) reported its first quarter 2026 financial results on May 14, 2026, and the numbers fell short of analyst expectations. The genomic medicine company posted revenue of $1.44 million for Q1 2026, significantly below the consensus estimate of $34.4 million. On the …